Skip to Main Content

Paper Details

Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202.
Pharmacogenet Genomics
8
2017
AIDS, APOA5, APOE rs7412, ATV, CD4, CD4+, CD4+ T-cell, CYPB26 rs3745274, EFV, HIV, HIV-1, HIV-1 RNA, PARTICIPANTS, atazanavir, cholesterol, efavirenz, low-density lipoprotein -cholesterol, low-density lipoprotein-cholesterol, patients, polymorphisms, rs651821, triglyceride, triglycerides
Author NameAffiliation
Anurag VermaaThe Center for Systems Genomics, The Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park bBiomedical and Translational Informatics, Pennsylvania cLos Angeles Biomedical Research Institute at Harbor, university of california los angeles Medical Center, California dUniversity of Rochester Medical Center, Rochester eDepartment of Pharmacy Practice, Center for Integrated Global Biomedical Sciences, University at Buffalo, New York fVanderbilt University School of Medicine gMeharry Medical College
  • 1 - 1

Datasets

PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink